NCT00000765View on ClinicalTrials.gov

Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2002

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

Trial Locations (9)

10016

Bellevue Hosp / New York Univ Med Ctr, New York

33316

Broward Gen Med Ctr, Fort Lauderdale

60612

Univ of Illinois, Chicago

75235

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

77006

Houston Clinical Research Network, Houston

90048

Cedars Sinai Med Ctr, Los Angeles

94304

Palo Alto Veterans Administration Med Ctr, Palo Alto

212872080

Johns Hopkins Univ School of Medicine, Baltimore

02906

Miriam Hosp / Brown Univ, Providence

Sponsors

Collaborators (1)

Glaxo Wellcome
All Listed Sponsors
collaborator

Glaxo Wellcome

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000765 - Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo) | Biotech Hunter | Biotech Hunter